Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Conditions: Hypertension; Hypercholesterolemia Interventions: Drug: Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg Sponsors: Yuhan Corporation Active, not recruiting

Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials